Yahoo! JAPAN

2024/5/29 -Among these innovations, SMART-C® has emerged as a valuable tool for veterinarians, offering new opportunities to enhance patient care and streamline procedures ...

2024/4/7 -In brief, SMART-C includes investigators of all large, placebo-controlled, phase 3 outcomes trials of SGLT2i, allowing for sharing of trial data across the ...

2024/6/4 -Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation. 2024 Jun 4;149(23): ...

2024/4/18 -SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events · Moderate-to-Severe Alopecia Areata Patients More Likely Than Mild Cases to Develop Eczema.

2024/4/5 -EFFECTS OF SGLT2 INHIBITORS ON CARDIOVASCULAR OUTCOMES WITH AND WITHOUT BASELINE USE OF GLP-1 RECEPTOR AGONISTS: A SMART-C COLLABORATIVE META-ANALYSISOpen ...

2024/5/29 -The latest news from Turner Imaging Systems innovative X-ray fluoroscopy device the SMART-C® mini C-arm that provides portability & flexibility.

2024/6/10 -Epigenetics Smart C Complex pack of 60 capsules are a pure food supplement, manufactured in a high quality production facility in the UK.

2024/3/22 -The SMART-C® is an innovative mini C-arm system by Turner Imaging Systems, designed for portability and flexibility in various medical settings.

2024/4/5 -The SGLT2i meta-analysis cardio-renal trialists consortium (SMART-C) includes all placebo-controlled RCTs of SGLT2i across 3 groups of pts: DM at high risk for ...

2024/6/4 -The agile SMART-C system, renowned for its wireless and battery-operated functionality, offers unparalleled portability and maneuverability, making it an ...